Research Institute of Orlando is a clinical research site located in Orlando, Florida, United States 32806.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
Research Institute of Orlando has participated in 8 clinical trials with 2 currently active.
Therapeutic areas: Developmental and Epileptic Encephalopathy, Dravet Syndrome, Lennox-Gastaut Syndrome.
Sponsors: Longboard Pharmaceuticals, LivaNova, Biohaven Therapeutics Ltd..
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Research Institute of Orlando has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Research Institute of Orlando has 8 clinical trials on record, with 2 currently active. Their work covers Developmental and Epileptic Encephalopathy, Dravet Syndrome, Lennox-Gastaut Syndrome.
Yes — Research Institute of Orlando holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.